Had a read up on Emyria last night, seems they have a few clinics (7) for unmet needs patients, basically people not responding to treatments (for pain), so they try them on cannabis.
They will use the data they gather from these clinics to supports clinical trials/registrations.
None of their drugs are in any FDA trial phase.
Couldn't quite understand the hype, but their market cap is slightly higher than ours.
Personally I'm going to stick with BOT, top up again, and if it means going down with the ship then so be it. Don't try this at home kids.
Bot Chart, page-4960
-
- There are more pages in this discussion • 9,240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 35.5¢ | $1.465M | 4.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 186321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 561591 | 7 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |